Skip to content

Validating a Delirium Prediction Model for Critically Ill Patients

Validating a Delirium Prediction Model for Critically Ill Patients

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00961389
Enrollment
650
Registered
2009-08-19
Start date
2009-05-31
Completion date
2009-10-31
Last updated
2009-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Delirium

Keywords

delirium, critical care, risk factors, prediction, inflammation

Brief summary

The objective of this study is to determine the incidence of delirium in adults patients who are admitted at the critical care unit of a Dutch University Hospital with the mapping of relevant delirium risk factors The primary aim is to validate the investigators' developed delirium prediction model for critical care patients. A secondary aim is to find differences between delirious patients and non-delirious patients on different aspects of diagnostics, treatment and care, outcome, length of stay, and inflammation. According to Dutch law, the need to obtain informed consent was waived by the Committee on Research Involving Human Subjects (CMO) of Nijmegen for this observational study (2007/283).

Interventions

None listed

Sponsors

Radboud University Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* all adult patients (18 years and older) admitted at the critical care unit of our hospital

Exclusion criteria

* admitted \< 12 hours on ICU * not able to understand Dutch * patients with serious hearing and visibility disabilities * mentally retarded patients * patients suffering from receptive aphasia * delirious before admission

Design outcomes

Primary

MeasureTime frame
deliriumduring admission at the critical care

Secondary

MeasureTime frame
markers of inflammationwithin 24 hours of delirium diagnosis

Countries

Netherlands

Contacts

Primary ContactMark van den Boogaard, MSc, R< CCRN
m.vandenboogaard@ic.umcn.nl+31243655618
Backup ContactPeter Pickkers, MD, PhD
p.pickkers@ic.umcn.nl+31243615363

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 27, 2026